230
Views
6
CrossRef citations to date
0
Altmetric
Review

Safety and efficacy of montelukast as adjunctive therapy for treatment of asthma in elderly patients

, , &
Pages 1329-1337 | Published online: 02 Oct 2013

References

  • ZureikMOrehekJDiagnosis and severity of asthma in the elderly: results of a large survey in 1,485 asthmatics recruited by lung specialistsRespiration200269322322812097765
  • World Health OrganizationAgeing and life course2013 Available from: http://www.who.int/ageing/en/Accessed July 25, 2013
  • BelliaVPedoneCCatalanoFAsthma in the elderly: mortality rate and associated risk factors for mortalityChest200713241175118217890479
  • BramanSSKaemmerlenJTDavisSMAsthma in the elderly. A comparison between patients with recently acquired and long-standing diseaseAm Rev Respir Dis199114323363401990949
  • ConnollyMJCrowleyJJCharanNBNielsonCPVestalREReduced subjective awareness of bronchoconstriction provoked by methacholine in elderly asthmatic and normal subjects as measured on a simple awareness scaleThorax19924764104131496497
  • CuttittaGCibellaFBelliaVChanges in FVC during methacholine-induced bronchoconstriction in elderly patients with asthma: bronchial hyperresponsiveness and agingChest200111961685169011399691
  • EkiciMApanAEkiciAErdemogluAKPerception of bronchocon-striction in elderly asthmaticsJ Asthma200138869169611758898
  • LawMMorrisJKWaldNLuczynskaCBurneyPChanges in atopy over a quarter of a century, based on cross sectional data at three time periodsBMJ200533075011187118815833748
  • LinnebergAGislumMJohansenNHusemoenLLJorgensenTTemporal trends of aeroallergen sensitization over twenty-five yearsClin Exp Allergy20073781137114217651142
  • ScichiloneNAugugliaroGTogiasABelliaVShould atopy be assessed in elderly patients with respiratory symptoms suggestive of asthma?Expert Rev Respir Med20104558559120923338
  • MathurSKSchwantesEAJarjourNNBusseWWAge-related changes in eosinophil function in human subjectsChest2008133241241918252914
  • FabbriLMRomagnoliMCorbettaLDifferences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2003167341842412426229
  • ten BrinkeAZwindermanAHSterkPJRabeKFBelEHFactors associated with persistent airflow limitation in severe asthmaAm J Respir Crit Care Med2001164574474811549526
  • Di LorenzoGMansuetoPDittaVSimilarity and differences in elderly patients with fixed airflow obstruction by asthma and by chronic obstructive pulmonary diseaseRespir Med2008102223223818006291
  • GraysonMHKorenblatPETreating asthma in the older patient: is there a place for leukotriene modifiers?Drugs Aging200623645145916872230
  • BackMKumlinMCotgreaveIADahlenSEAn alternative pathway for metabolism of leukotriene D(4): effects on contractions to cysteinyl-leukotrienes in the guinea-pig tracheaBr J Pharmacol200113371134114411487525
  • MechicheHNalineECandenasLEffects of cysteinyl leukotrienes in small human bronchus and antagonist activity of montelukast and its metabolitesClin Exp Allergy200333788789412859443
  • BarnesNCPujetJCPranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthmaThorax19975265235279227718
  • BarnesNCMillerCJEffect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: an integrated analysis of zafirlukast trialsThorax200055647848310817796
  • HoriguchiTTachikawaSKondoRShigaMHiroseMItoTClinical effects of long-term administration of pranlukast, a leukotriene receptor antagonist, on adult patients with bronchial asthmaArzneimittelforschung2003531071472114650364
  • VaquerizoMJCasanPCastilloJEffect of montelukast added to inhaled budesonide on control of mild to moderate asthmaThorax200358320421012612294
  • BozekAWarkocka-SzoltysekBFilipowska-GronskaAJarzabJMontelukast as an add-on therapy to inhaled corticosteroids in the treatment of severe asthma in elderly patientsJ Asthma201249553053422551116
  • BarnesNThomasMPriceDTateHThe national montelukast surveyJ Allergy Clin Immunol20051151475415637546
  • OhshimaNMatsuiHMatsuiYAddition of leukotriene receptor antagonists to inhaled corticosteroids improved QOL of patients with bronchial asthma surveyed in suburban Tokyo, JapanAllergol Int201160447348121681017
  • YasuiHFujisawaTInuiNImpact of add-on pranlukast in stable asthma; the additive effect on peripheral airway inflammationRespir Med2012106450851422265857
  • Global Initiative for AsthmaGlobal Strategy for Asthma Management and Prevention2012 Available from: http://www.ginasthma.org/Accessed August 27, 2013
  • DahlenSEMalmstromKNizankowskaEImprovement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trialAm J Respir Crit Care Med2002165191411779723
  • CamargoCAJrSmithlineHAMaliceMPGreenSAReissTFA randomized controlled trial of intravenous montelukast in acute asthmaAm J Respir Crit Care Med2003167452853312456380
  • CamargoCAJrGurnerDMSmithlineHAA randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthmaJ Allergy Clin Immunol2010125237438020159247
  • National Asthma Education and Prevention ProgramConsiderations for diagnosing and managing asthma in the elderly NIH publication 1996; No 96-3662. Available from: http://msdh.ms.gov/msdhsite/_static/resources/2107/pdfAccessed July 26, 2013
  • DolovichMBAhrensRCHessDRDevice selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and ImmunologyChest2005127133537115654001
  • LaforestLDenisFVan GanseECorrelates of adherence to respiratory drugs in COPD patientsPrim Care Respir J201019214815420094689
  • ScichiloneNSpataforaMBattagliaSArrigoRBenfanteABelliaVLung penetration and patient adherence considerations in the management of asthma: role of extra-fine formulationsJ Asthma Allergy20136112123378776
  • GangemiSPescaraLD’UrbanoEAging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levelsExp Gerontol200540761261415935589
  • VachierIBonnansCChavisCSevere asthma is associated with a loss of LX4, an endogenous anti-inflammatory compoundJ Allergy Clin Immunol20051151556015637547
  • KorenblatPEKempJPSchergerJEMinkwitzMCMezzanotteWEffect of age on response to zafirlukast in patients with asthma in the Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT)Ann Allergy Asthma Immunol200084221722510719780
  • CreticosPKnobilKEdwardsLDRickardKADorinskyPLoss of response to treatment with leukotriene receptor antagonists but not inhaled corticosteroids in patients over 50 years of ageAnn Allergy Asthma Immunol200288440140911991558
  • NyenhuisSMSchwantesEAMathurSKCharacterization of leukotrienes in a pilot study of older asthma subjectsImmun Ageing20107820602786
  • HoriguchiTTachikawaSKondoRComparative evaluation of the leukotriene receptor antagonist pranlukast versus the steroid inhalant fluticasone in the therapy of aged patients with mild bronchial asthmaArzneimittelforschung2007572879117396618
  • WilliamsBNoonanGReissTFLong-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and olderClin Exp Allergy200131684585411422148
  • RandCBilderbackASchillerKEdelmanJMHustadCMZeigerRSAdherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trialJ Allergy Clin Immunol2007119491692317349681
  • StormsWMicheleTMKnorrBClinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged ≥6 yearsClin Exp Allergy2001311778711167954
  • PearlmanDSWhiteMVLiebermanAKFluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthmaAnn Allergy Asthma Immunol200288222723511868930
  • RobinsonDSCampbellDBarnesPJAddition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trialLancet200135792732007201111438132
  • VirchowJCBachertCEfficacy and safety of montelukast in adults with asthma and allergic rhinitisRespir Med2006100111952195916626955
  • RussmannSIselinHUMeierDAcute hepatitis associated with montelukastJ Hepatol200338569469512713887
  • TuggeyJMHoskerHSChurg-Strauss syndrome associated with montelukast therapyThorax200055980580610950903
  • BackMLeukotriene signaling in atherosclerosis and ischemiaCardiovasc Drugs Ther2009231414818949546
  • IngelssonEYinLBackMNationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular diseaseJ Allergy Clin Immunol20121293702707. e70222244598
  • HananiaNAKingMJBramanSSAsthma in the elderly: Current understanding and future research needs – a report of a National Institute on Aging (NIA) workshopJ Allergy Clin Immunol2011128Suppl 3S4S2421872730
  • JayaramLDuongMPizzichiniMMFailure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthmaEur Respir J2005251414615640321